drugset / Trial / NCT04069689
Study of Safety and Pharmacokinetics of Oral Doses of EPX-100 in Healthy Subjects.
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a placebo-controlled, double-blind, 2-period study in 3 sequential groups of 8 healthy subjects each. The safety and pharmacokinetics of escalating single and multiple oral doses of EPX-100 will be assessed in fasting healthy subjects and following a high-fat meal.
Timeline
- Start
- 2019-08-29
- Primary completion
- 2019-11-27
- Completion
- 2019-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clemizole | Small molecule | 20 mg | Oral |
| Subject | Clemizole | Small molecule | 40 mg | Oral |
| Subject | Clemizole | Small molecule | 80 mg | Oral |